Biotech with large Triangle presence buying Maryland firm for $1.2B
Catalent Inc., a New Jersey-based contract drug manufacturer with a large Triangle presence, said Monday it will acquire Maryland's Paragon Bioservices Inc. for $1.2 billion. Catal…
Catalent Inc., a New Jersey-based contract drug manufacturer with a large Triangle presence, said Monday it will acquire Maryland's Paragon Bioservices Inc. for $1.2 billion. Catal…